Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant peripheral nerve sheath tumors: an update.

Bruno Fuchs1, Robert J Spinner, Michael G Rock

  • 1Balgrist University Hospital, University of Zurich, Zurich, Switzerland.

Journal of Surgical Orthopaedic Advances
|January 31, 2006
PubMed
Summary

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas. Diagnosis involves immunohistochemistry, molecular analysis, and advanced imaging like MRI for effective management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value operating system: a practical framework to measure outcomes-per-cost at the episode level.

BMJ open quality·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Twelve-Month Metastatic State as a Landmark-Based Prognostic Stratifier in Metastatic Sarcoma.

Cancers·2026
Same author

Locked-Window EQ-5D-5L (Index and VAS) Benchmarking in Sarcoma Care: Rule-Based Traffic-Light Classification Across Two Institutions.

Diseases (Basel, Switzerland)·2026

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive soft tissue sarcomas, comprising 5-10% of all sarcomas.
  • MPNSTs arise sporadically, in association with neurofibromatosis type 1 (NF1), or post-radiation therapy.
  • Histologically, MPNSTs resemble fibrosarcomas, necessitating specific diagnostic markers.

Purpose of the Study:

  • To outline the diagnostic and management strategies for MPNSTs.
  • To highlight the role of various diagnostic modalities in identifying MPNSTs.
  • To emphasize the importance of a multidisciplinary approach in treating these tumors.

Main Methods:

  • Histopathological examination with immunohistochemistry (e.g., S100).
  • Molecular analysis focusing on NF1 gene status and Ras-activity.

Related Experiment Videos

  • Advanced imaging techniques including Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans.

    • Main Results:

    • Immunohistochemistry, particularly S100, is crucial for diagnosis.
    • Loss of the NF1 gene and elevated Ras-activity are key molecular features.
    • MRI aids in defining tumor extent and neurogenic origin; PET scans can detect malignant changes.

    Conclusions:

    • MPNST diagnosis requires a combination of histological, molecular, and imaging findings.
    • Multidisciplinary team management is essential for complete surgical resection.
    • The aggressive nature of MPNSTs is reflected in poor survival statistics, underscoring the need for timely and comprehensive treatment.